| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 6.303 | 12.814 | 14.561 | 11.977 | 14.725 | 13.027 |
| Total Income - EUR | 0 | 267 | 0 | 0 | 6.303 | 12.814 | 14.561 | 11.978 | 14.725 | 13.027 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 504 | 691 | 1.315 | 2.591 | 3.311 |
| Gross Profit/Loss - EUR | 0 | 267 | 0 | 0 | 6.303 | 12.310 | 13.870 | 10.662 | 12.134 | 9.716 |
| Net Profit/Loss - EUR | 0 | 259 | 0 | 0 | 6.078 | 11.934 | 13.442 | 10.346 | 10.193 | 8.161 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr.grujic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.747 | 2.719 | 2.673 | 2.624 | 2.573 | 2.525 | 2.469 | 2.476 | 1.185 | 0 |
| Current Assets | 14.116 | 757 | 744 | 730 | 6.905 | 12.680 | 13.797 | 12.277 | 13.479 | 15.540 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 228 | 226 | 222 | 218 | 190 | 186 | 182 | 183 | 182 | 0 |
| Cash | 13.888 | 531 | 522 | 512 | 6.715 | 12.494 | 13.615 | 12.095 | 13.297 | 15.540 |
| Shareholders Funds | 16.864 | 535 | 526 | 517 | 6.584 | 12.605 | 13.639 | 10.644 | 10.241 | 8.210 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 2.941 | 2.891 | 2.838 | 2.894 | 2.599 | 2.627 | 4.110 | 4.423 | 7.330 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr.grujic Srl